Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
USPSTF No Longer Recommends Daily Aspirin for the Prevention of Heart Attack, Stroke for All Patients
10/12/2021
In a new recommendation from the US Preventive Services Task Force, prescriptions for a daily regimen of low-dose aspirin for most people at high risk of a first heart attack or stroke should no longer be prescribed.
In a new recommendation from the US Preventive Services Task Force, prescriptions for a daily regimen of low-dose aspirin for most people at high risk of a first heart attack or stroke should no longer be prescribed.
In a new recommendation from the...
10/12/2021
Pharmacy Learning Network
News
Research Identifies OTC Meds Commonly Involved in Drug-Drug Interactions
10/08/2021
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,” Dr Oliver wrote, “was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and...
“The most significant finding,”...
10/08/2021
Pharmacy Learning Network
News
Opioid Analgesic Recalled
10/07/2021
Fresenius Kabi USA is recalling four lots of morphine sulfate injection because of cracked vials and a subsequent lack of sterility assurance.
Fresenius Kabi USA is recalling four lots of morphine sulfate injection because of cracked vials and a subsequent lack of sterility assurance.
Fresenius Kabi USA is recalling...
10/07/2021
Pharmacy Learning Network

Advertisement

News
Anticonvulsant Recalled
10/07/2021
The FDA issued a Class II recall for a prescription medication used to treat seizures and bipolar disorder
The FDA issued a Class II recall for a prescription medication used to treat seizures and bipolar disorder
The FDA issued a Class II recall...
10/07/2021
Pharmacy Learning Network
News
Cold and Flu Relief Medication Recalled
10/07/2021
An over-the-counter pain reliever, fever reducer, cough suppressant/expectorant, and nasal decongestant is being recalled.
An over-the-counter pain reliever, fever reducer, cough suppressant/expectorant, and nasal decongestant is being recalled.
An over-the-counter pain...
10/07/2021
Pharmacy Learning Network
News
Recall Expanded to Include All Lots of Smoking Cessation Tablets
09/30/2021
Pfizer is voluntarily recalling all lots of a smoking cessation drug due to a nitrosamine impurity.
Pfizer is voluntarily recalling all lots of a smoking cessation drug due to a nitrosamine impurity.
Pfizer is voluntarily recalling...
09/30/2021
Pharmacy Learning Network

Advertisement

News
Anticonvulsant Recalled
09/30/2021
The FDA issued a Class II recall for a prescription anticonvulsant used with other medications to prevent seizures.
The FDA issued a Class II recall for a prescription anticonvulsant used with other medications to prevent seizures.
The FDA issued a Class II recall...
09/30/2021
Pharmacy Learning Network
News
Beta Blocker Recalled
09/30/2021
A Class II recall was issued for a prescription beta blocker after a metal wire was found in a tablet.
A Class II recall was issued for a prescription beta blocker after a metal wire was found in a tablet.
A Class II recall was issued for...
09/30/2021
Pharmacy Learning Network
News
Opioid Analgesic Recalled
09/23/2021
Rhodes Pharmaceuticals is recalling oxycodone hydrochloride tablets because a hydrochlorothiazide-lisinopril tablet was found in a bottle.
Rhodes Pharmaceuticals is recalling oxycodone hydrochloride tablets because a hydrochlorothiazide-lisinopril tablet was found in a bottle.
Rhodes Pharmaceuticals is...
09/23/2021
Pharmacy Learning Network

Advertisement

News
Pharmacist Intervention Improved PPI Use Among Patients With Heartburn, Other Acid-related Disorders
09/23/2021
“In a busy inpatient setting, we developed a feasible way to assess PPI therapy, deimplement nonguideline-concordant PPI use, and provide follow-up to assess any unintended consequences,” explained researchers.
“In a busy inpatient setting, we developed a feasible way to assess PPI therapy, deimplement nonguideline-concordant PPI use, and provide follow-up to assess any unintended consequences,” explained researchers.
“In a busy inpatient setting, we...
09/23/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use